Regression coefficient B | SE | β | T | Significance | ||
suPAR | Constant | 2 826 297 | 989 168 | 2.857 | 0.006 | |
Age | 21.702 | 8.268 | 0.296 | 2.625 | 0.011 | |
Potassium | −507.487 | 223.642 | −0.256 | −2.269 | 0.026 | |
F=5.6; p<0.01; r2 adj: 0.116 | ||||||
sST2 | Constant | 5982.284 | 3471.769 | 1.723 | 0.090 | |
Sex | 3986.780 | 1272.989 | 0.713 | 3.132 | 0.003 | |
Body muscle | −319.276 | 137.530 | −0.490 | −2.322 | 0.023 | |
Alkaline phosphatase | 17.703 | 6.755 | 0.273 | 2.621 | 0.011 | |
Creatinine | 4307.157 | 2440.313 | 0.249 | 1.765 | 0.082 | |
F=8.96; p<0.001; r2 adj: 0.319 | ||||||
H-FABP | Constant | 14.560 | 7.552 | 1.928 | 0.058 | |
Uric acid | 0.131 | 0.062 | 0.228 | 2.117 | 0.038 | |
LDL-C | −0.017 | 0.008 | −0.691 | −2.249 | 0.028 | |
Apolipoprotein B | 0.029 | 0.010 | 0.896 | 2.811 | 0.007 | |
F=7.7; p<0.001; r2 adj: 0.324 |
Significant predictors for suPAR, sST2 and H-FABP according to the backwards multiple linear regression analysis.
H-FABP, heart-type fatty acid-binding protein; LDL-C, low-density lipoprotein-cholesterol; sST2, soluble isoform of suppression of tumorigenicity 2; suPAR, soluble urokinase-type plasminogen activator receptor.